Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,299
Total Claims
$943K
Drug Cost
635
Beneficiaries
$1,485
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-75%
Opioid rate vs peers
0.6% vs 2.2% avg
+5%
Cost per patient vs peers
$1,485 vs $1,411 avg
+10%
Brand preference vs peers
11.7% vs 10.6% avg
Opioid Prescribing
0.6%
Opioid Rate
64
Opioid Claims
$298
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,307 claims · $712K
Generic: 9,905 claims · $224K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 60 | $81K |
| Insulin Glargine,hum.Rec.Anlog | 84 | $79K |
| Sitagliptin Phosphate | 60 | $76K |
| Semaglutide | 47 | $75K |
| Empagliflozin | 51 | $64K |
| Rivaroxaban | 30 | $36K |
| Dulaglutide | 17 | $29K |
| Dapagliflozin Propanediol | 12 | $21K |
| Mirabegron | 15 | $20K |
| Insulin Aspart | 23 | $19K |
| Budesonide/Formoterol Fumarate | 39 | $19K |
| Insulin Lispro | 26 | $18K |
| Fluticasone Propion/Salmeterol | 32 | $17K |
| Fluticasone Propion/Salmeterol | 21 | $13K |
| Fluticasone Propion/Salmeterol | 25 | $12K |
Prescribing Profile
Patient Profile
71
Avg Age
72%
Female
1.45
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About